Soft tissue sarcoma
Soft Tissue Sarcomas are malignant tumours which arise from the soft tissue of the body – also in the connective tissue and muscle. It is a relatively rare form of cancer, although more commonly found in children and adolescents than other age groups. Currently on average two new people per 100,000 develop a soft tissue sarcoma each year.
Sarcomas are classified by the tissue that they emerge from: adipose (fat) tissue, connective tissue, vessels, tendons, joint capsules, muscles or musculocutaneous nerve. The lower extremities are typical location for a soft part sarcoma. Around 60 percent of all sarcoma tumours can be found in the arms or legs, one-third arise in the torso, and occasionally they can be found in the neck and face area.
Numerous risk factors for the development of a soft tissue sarcoma have been described, but they explain only a fraction of the sarcomas. Chemical carcinogens can play a role in their formation. Soft tissue sarcomas are often found in the context of genetic diseases, and to a lesser extent, a familial predisposition.
For the formation of Kaposi, the Human herpes virus (HHV) 8 is responsible. This works fastest in an immunocompromised organism (patients with HIV-1).
A frequent occurrence of tissue injury on random parts of the body is observable. Sarcomas can often be found around operation or burn scars, and previous tissue transplants. In addition there is a significant association with radiation, such as radio-therapy or radioactive exposure.
Space-occupying tumours can be detected depending on the location. Patients often complain about pain in the affected regions. This includes a local pressure or tensile feeling. But also neurological complaints by trapped nerves and circulatory disorders by vascular compression can occur.
Basically with any new mass, unless it is an absolutely non-malignant origin, a biopsy should be carried out. Sarcomas are diagnosed by X-ray, computed tomography, and magnetic resonance imaging. For the differential diagnosis, is always a biopsy required.
Recommended therapies for the treatment of soft tissue sarcoma:
The healing effect of whole-body hyperthermia for patients with tissue sarcoma is that we can very quickly bring the organism to high temperatures (up 40.5 °). This fast and high heating activates not only the immune system, but many degenerate cells of the soft tissue sarcomas are destroyed by the fast floods of heat. In addition to the damage or removal of the cancer cells, the whole-body hyperthermia activates the immune system without burdening the rest of the body. It triggers an immune cascade that enables the white blood cells to multiply.
Infusions high-dose Vitamin C
Vitamin C is probably the best known vitamin. So-called Ascorbic acid is the most important antioxidant, i.e. it intercepts harmful free radicals in the body and makes them harmless – and in this way prevents degeneration in the cells. Vitamin C is also essential for the immune system and various restructuring processes in the body. When vitamin C is given in a high dose, many diseases can be positively affected.
The nutritional therapy of Dr.Gerson aims at detoxifying the body with simultaneous addition of many fresh nutrients, which is particularly useful for patients with soft tissue sarcomas. This therapy is offered directly at the hyperthermia Centre Hannover. In addition to special juices, fresh and elaborately prepared and taken throughout the day including high-quality fruits and vegetables. Carefully prepared partly as fresh food, partly in special soups or gently cooked and steamed to retain their healing powers. The Gerson therapy is low in fat, low in sodium and proteins.
Patients with tissue sarcoma can benefit from the healing-effects of an oncolytic virotherapy. A virotherapy uses viruses to destroy cancer cells with very few side-effects. The Virotherapy itself consists of several injections according to a predetermined Virotherapy treatment protocol. Dr. Mohamed Ali Zayen is a certified specialist of Virotherapy RIGVIR®. Our Virotherapy protocol is an outpatient treatment and provided to you according to an individual treatment plan. The interval of RIGVIR® injection is different from one protocol to another.